Cystic fibrosis Respiratory
Conditions
Interventions
This is a one year randomised controlled trial. There will be 400 adult participants from 6 CF specialist centres across the UK. Potential participants will be approached regarding the study by the re
Sponsors
Papworth Hospital NHS Foundation Trust
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosis of Cystic Fibrosis based on genetic testing and/or sweat chloride levels 2. Age >=18 years of age 3. Able to provide written informed consent 4. Patients who are known to be suitable for home monitoring and able to manage the process or those currently undertaking home monitoring
Exclusion criteria
Exclusion criteria: 1. Patients unable to provide written informed consent 2. Patients unwilling to consent to their link anonymized data from home monitoring being used for research 3. Patients unable to perform regular home monitoring 4. Lung transplant recipients 5. Patients participating in an interventional medicinal research study within the preceding 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life using Cystic Fibrosis Revised Questionnaire (CFQR) at baseline and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Lung function (FEV1 % predicted) at baseline and 12 months 2. Number of days requiring antibiotics for acute pulmonary exacerbation at baseline and 12 months | — |
Countries
England, Northern Ireland, Scotland, United Kingdom, Wales
Contacts
Public ContactLucy Gale
Outcome results
None listed